160 related articles for article (PubMed ID: 9682919)
1. Role of the ouabain-like factor and Na-K pump in rat and human genetic hypertension.
Ferrandi M; Manunta P; Rivera R; Bianchi G; Ferrari P
Clin Exp Hypertens; 1998; 20(5-6):629-39. PubMed ID: 9682919
[TBL] [Abstract][Full Text] [Related]
2. Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays.
Ferrandi M; Manunta P; Balzan S; Hamlyn JM; Bianchi G; Ferrari P
Hypertension; 1997 Oct; 30(4):886-96. PubMed ID: 9336389
[TBL] [Abstract][Full Text] [Related]
3. Ouabainlike factor in Milan hypertensive rats.
Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
[TBL] [Abstract][Full Text] [Related]
4. Secretion of a lactone-hydrogenated ouabain-like effector of sodium, potassium-adenosine triphosphatase activity by adrenal cells.
Qazzaz HM; El-Masri MA; Valdes R
Endocrinology; 2000 Sep; 141(9):3200-9. PubMed ID: 10965891
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of a ouabain-like factor from Milan hypertensive rats.
Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S75-8. PubMed ID: 7508036
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of Na-K-ATPase in human urine: effects of ouabain-like factors and of vanadium-diascorbate on calcium mobilization in rat vascular smooth muscle cells: comparison with the effects of ouabain, angiotensin II, and arginine-vasopressin.
Meyer-Lehnert H; Bäcker A; Kramer HJ
Am J Hypertens; 2000 Apr; 13(4 Pt 1):364-9. PubMed ID: 10821337
[TBL] [Abstract][Full Text] [Related]
7. Human adrenal cells in culture produce both ouabain-like and dihydroouabain-like factors.
el-Masri MA; Clark BJ; Qazzaz HM; Valdes R
Clin Chem; 2002 Oct; 48(10):1720-30. PubMed ID: 12324489
[TBL] [Abstract][Full Text] [Related]
8. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
Kramer HJ; Krampitz G; Bäcker A; Michel H; Krampitz G; Meyer-Lehnert H
Am J Hypertens; 1995 Jul; 8(7):753-60. PubMed ID: 7546503
[TBL] [Abstract][Full Text] [Related]
9. PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension.
Ferrari P; Ferrandi M; Tripodi G; Torielli L; Padoani G; Minotti E; Melloni P; Bianchi G
J Pharmacol Exp Ther; 1999 Mar; 288(3):1074-83. PubMed ID: 10027844
[TBL] [Abstract][Full Text] [Related]
10. Ouabain-like factors in human urine: identification of a Na-K-ATPase inhibitor as vanadium-diascorbate adduct.
Kramer HJ; Krampitz G; Bäcker A; Meyer-Lehnert H
Clin Exp Hypertens; 1998; 20(5-6):557-71. PubMed ID: 9682912
[TBL] [Abstract][Full Text] [Related]
11. Age-dependency and dietary influence on the hypothalamic ouabain-like factor in Milan hypertensive rats.
Ferrandi M; Minotti E; Florio M; Bianchi G; Ferrari P
J Hypertens; 1995 Dec; 13(12 Pt 2):1571-4. PubMed ID: 8903611
[TBL] [Abstract][Full Text] [Related]
12. PST 2238: a new antihypertensive compound that modulates the Na-K pump 'in vivo' and 'in vitro'.
Ferrari P; Ferrandi M; Torielli L; Tripodi G; Bianchi G
Hypertens Res; 2000 Sep; 23 Suppl():S15-9. PubMed ID: 11016814
[TBL] [Abstract][Full Text] [Related]
13. Endogenous immunoreactive ouabain-like and digoxin-like factors in reduced renal mass hypertensive rats.
Takada T; Nakagawa M; Ura N; Kaide J; Yoshida H; Shimamoto K
Hypertens Res; 1998 Sep; 21(3):193-9. PubMed ID: 9786604
[TBL] [Abstract][Full Text] [Related]
14. Production of ouabain-like factor in normal and ischemic rat heart.
D'Urso G; Frascarelli S; Balzan S; Zucchi R; Montali U
J Cardiovasc Pharmacol; 2004 May; 43(5):657-62. PubMed ID: 15071352
[TBL] [Abstract][Full Text] [Related]
15. Role of ouabain-like factors and Na-K-ATPase inhibitors in hypertension--some old and recent findings.
Haddy FJ; Pamnani MB
Clin Exp Hypertens; 1998; 20(5-6):499-508. PubMed ID: 9682906
[TBL] [Abstract][Full Text] [Related]
16. Cellular mechanisms of action of a ouabain-like factor in vascular smooth-muscle cells.
Meyer-Lehnert H; Wanning C; Michel H; Bäcker A; Kramer HJ
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S16-9. PubMed ID: 7508017
[TBL] [Abstract][Full Text] [Related]
17. Evidence of an endogenous ouabain-like immunoreactive compound with digitalis-like properties in the human.
Balzan S; Montali U; Ghione S
Ann N Y Acad Sci; 1997 Nov; 834():626-30. PubMed ID: 9405875
[No Abstract] [Full Text] [Related]
18. Endogenous digitalislike circulating substances in spontaneously hypertensive rats.
Wauquier I; Pernollet MG; Grichois ML; Lacour B; Meyer P; Devynck MA
Hypertension; 1988 Aug; 12(2):108-16. PubMed ID: 2457551
[TBL] [Abstract][Full Text] [Related]
19. Ouabain-like factor.
Goto A; Yamada K
Curr Opin Nephrol Hypertens; 1998 Mar; 7(2):189-96. PubMed ID: 9529622
[TBL] [Abstract][Full Text] [Related]
20. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
